Prestige BioPharma Limited (KRX:950210)
South Korea · Delayed Price · Currency is KRW 12,030
-180 (-1.47%)
At close: Jan 16, 2026
Prestige BioPharma Market Cap
Prestige BioPharma has a market cap or net worth of 144.59 billion as of January 16, 2026. Its market cap has decreased by -25.65% in one year.
Market Cap
144.59B
Enterprise Value
227.25B
Revenue
14.41B
Ranking
n/a
PE Ratio
45.85
Stock Price
12,030.00
Market Cap Chart
Since May 28, 2021, Prestige BioPharma's market cap has decreased from 360.58B to 144.59B, a decrease of -59.90%. That is a compound annual growth rate of -17.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 144.59B | -6.38% |
| Dec 30, 2025 | 154.45B | -14.96% |
| Dec 30, 2024 | 181.61B | 59.39% |
| Dec 28, 2023 | 113.94B | 29.33% |
| Dec 29, 2022 | 88.10B | -64.84% |
| Dec 30, 2021 | 250.60B | -30.50% |
| May 28, 2021 | 360.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 89.20T |
| Celltrion | 46.28T |
| ALTEOGEN | 24.98T |
| ABL Bio | 10.60T |
| SK Biopharmaceuticals | 9.51T |
| Yuhan | 8.15T |
| HLB Co., Ltd. | 6.91T |
| LigaChem Biosciences | 5.93T |